NVS
Novartis AG
DRUG MANUFACTURERS - GENERAL · HEALTHCARE
Novartis AG (ADR), based in Basel, Switzerland, is a premier global healthcare leader specializing in the research, development, manufacturing, and commercialization of innovative pharmaceuticals and medical devices. The company boasts a comprehensive portfolio of patented therapies across crucial t...
$154.03
-0.68% ($1.05)
Volume
2.63M
52W High
$170.46
52W Low
$97.72
Market Cap
$219.89B
What to Watch This Quarter
Based on historical dataConsensus EPS
$1.99
Whisper EPS
$2.05
3.2% above consensus
Last Quarter
$2.03
Current Streak
1 Beat
Avg Surprise (4Q)
-0.55%
Next Earnings Report
Reports in 21 days
Price Chart
EPS History: Consensus vs Actual
Last 12 quartersPrice Movement Around Earnings
Q4 2025
Feb 4, 2026
1-Day:
+0.68%
5-Day:
+2.71%
Q3 2025
Oct 28, 2025
1-Day:
-1.32%
Q2 2025
Jul 17, 2025
1-Day:
-0.24%
5-Day:
+2.02%
Q1 2025
Apr 29, 2025
1-Day:
+0.04%
Revenue & Financial Performance
Revenue Whisper
$14.15B
TWN Proprietary Estimate
Last Quarter Revenue
$13.33B
-1.6% YoY
Gross Margin
73.4%
Net Margin: 18.1%
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'25 | $13.33B | -1.6% | 73.4% | 26.4% | $2.41B |
| Q3'25 | $14.36B | +9.0% | 75.4% | 31.4% | $3.93B |
| Q2'25 | $14.84B | +15.3% | 77.6% | 32.8% | $4.04B |
| Q1'25 | $13.62B | +12.4% | 76.3% | 34.2% | $3.61B |
| Q4'24 | $13.56B | +15.1% | 75.5% | 26.0% | $2.82B |
| Q3'24 | $13.17B | +8.9% | 75.5% | 27.5% | $3.19B |
| Q2'24 | $12.87B | +9.6% | 75.4% | 31.2% | $3.25B |
| Q1'24 | $12.12B | +9.7% | 74.5% | 27.8% | $2.69B |
Company Information
Symbol
NVS
Company
Novartis AG
Market Cap
$219.89B
Sector
HEALTHCARE
Next Earnings
Apr 28, 2026
Also Reporting Soon
Companies reporting earnings around the same time as NVS
HEALTHCARE Stocks
Other healthcare companies with earnings data
More in DRUG MANUFACTURERS - GENERAL
Compare NVS with competitors
Side-by-side earnings comparison